Transport features and structural optimization of solid lipid nanoparticles crossing the intestinal epithelium

被引:3
|
作者
Chai, Guihong [1 ,2 ]
Meng, Yufang [3 ]
Chen, Shaoqing [1 ]
Hu, Fuqiang [1 ]
Gan, Yong [2 ]
Yuan, Hong [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[3] Zhejiang Med Co Ltd, Xinchang Pharmaceut Factory, Xinchang 312500, Peoples R China
关键词
ORAL-DRUG DELIVERY; IN-VITRO; POLYMER NANOPARTICLES; MUCUS; ABSORPTION; MECHANISMS; PATHWAYS; SOLVENT; SYSTEMS; MODELS;
D O I
10.1039/c6ra12978a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Solid lipid nanoparticles (SLNs) have been used to encapsulate drugs with poor solubility and membrane permeability to improve oral bioavailability. In vitro experiments that determine the SLNs fabrication parameters necessary to achieve satisfactory absorption is important to avoid costly and timeconsuming animal experiments. In this study, the Madin-Darby canine kidney (MDCK) cell line was employed to construct a simulated epithelial cell monolayer, and the transport features of SLNs were investigated. Subsequently, SLNs prepared with solid lipid materials with different carbon chain lengths or modified with different amounts of polyethylene glycol monostearate (SA-PEG2000) were used to investigate the relationship between nanoparticle structures and transcytosis efficiency, and the related mechanisms were revealed. Moreover, rats were employed to compare the in vitro and in situ intestinal absorption of these various SLNs. The results demonstrated that the endocytosis and endocellular delivery of SLNs crossing the MDCK cell monolayer were vesicle-mediated processes. Studies of the transport capacity of various SLNs across the cell monolayer showed that the transcytosis of SLNs decreased with increasing carbon chain length, and improved with a certain amount of hydrophilic modification (SA-PEG2000, 20%, w/w). The analysis of molecular mechanisms demonstrated that SLNs prepared by solid lipid materials with a short carbon chain were inclined to be transcytosed via endoplasmic reticulum (ER)-and Golgi complex-mediated pathways; further, SLNs containing an increasingly long carbon chain showed proportionally lower transcytosis by these two organelles. Furthermore, a certain amount of hydrophilic modification can evade transcytosis via the ER-and Golgi complex-mediated pathways for more effective transcytosis. Moreover, the intestinal absorption results were consistent with that found in the simulated epithelial cell monolayer. In conclusion, SLNs prepared with solid lipid materials with a medium-length carbon chain and surface-modified with a certain amount of hydrophilic modification can transcytosis effectively.
引用
收藏
页码:70433 / 70445
页数:13
相关论文
共 50 条
  • [1] Transport mechanism of lipid covered saquinavir pure drug nanoparticles in intestinal epithelium
    Xia, Dengning
    He, Yuan
    Li, Qiuxia
    Hu, Cunde
    Huang, Wei
    Zhang, Yunhai
    Wan, Feng
    Wang, Chi
    Gan, Yong
    JOURNAL OF CONTROLLED RELEASE, 2018, 269 : 159 - 170
  • [2] Transmucosal Solid Lipid Nanoparticles to Improve Genistein Absorption via Intestinal Lymphatic Transport
    Obinu, Antonella
    Burrai, Giovanni Pietro
    Cavalli, Roberta
    Galleri, Grazia
    Migheli, Rossana
    Antuofermo, Elisabetta
    Rassu, Giovanna
    Gavini, Elisabetta
    Giunchedi, Paolo
    PHARMACEUTICS, 2021, 13 (02) : 1 - 17
  • [3] Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model
    Roger, Emilie
    Gimel, Jean-Christophe
    Bensley, Conor
    Klymchenko, Andrey S.
    Benoit, Jean-Pierre
    JOURNAL OF CONTROLLED RELEASE, 2017, 253 : 11 - 18
  • [4] Delivery of Nanoparticles across the Intestinal Epithelium via the Transferrin Transport Pathway
    Yong, Jing M.
    Mantaj, Julia
    Cheng, Yiyi
    Vllasaliu, Driton
    PHARMACEUTICS, 2019, 11 (07)
  • [5] Formulation, Optimization and Evaluation of Solid Lipid Nanoparticles of Lornoxicam
    Palei, Narahari N.
    Das, Malay K.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (10): : 1528 - 1537
  • [6] Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis
    Musielak, Ewelina
    Feliczak-Guzik, Agnieszka
    Nowak, Izabela
    MOLECULES, 2022, 27 (07):
  • [7] Optimization of itroconazole solid lipid nanoparticles for topical delivery
    Chaudhari P.M.
    Patil A.R.
    Nanoscience Nanotechnology - Asia, 2020, 4 (381-389): : 381 - 389
  • [8] Formulation Optimization and Characterization of Solid Lipid Nanoparticles of Apixaban
    Mulay, Laukik
    Hegde, Namita
    Kanugo, Abhishek
    RECENT PATENTS ON NANOTECHNOLOGY, 2025, 19 (02) : 270 - 281
  • [9] Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium
    des Rieux, A
    Ragnarsson, EGE
    Gullberg, E
    Préat, V
    Schneider, YJ
    Artursson, P
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 25 (4-5) : 455 - 465
  • [10] Structural Effects of Dibucaine Encapsulation into Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
    Casadei, Bruna R.
    Barbosa, Raquel de Melo
    Marcato, Priscyla D.
    Duran, Nelson
    de Paula, Eneida
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 344A - 344A